"What our study suggests is something broader: GLP-1 drugs may also quiet what I call 'drug noise,' the relentless craving that drives addiction across substances
Similar content being viewed by others Introduction In recent years, the incidence of diabetes mellitus (DM) and cardiovascular disease (CVD) has surged significantly
As a selective GLP-1 receptor agonist it engages receptors in the pancreas and central appetite-regulating regions of the brain, and in research it is studied for effects on satiety, food intake, glycemic control and body-weight reduction the compound anchoring the STEP obesity and SUSTAIN diabetes trial programs
Additional Information How to cite this article : Xin, Z
Vomiting, diarrhea and constipation are real, particularly in the first few weeks at a new dose level
Some people even lost up to 1/5th of their body weight